secwatch.observer — SEC 8-K summary
======================================

Issuer:     CNBX Pharmaceuticals Inc. (CNBX)
CIK:        0001343009
Form:       8-K
Filed at:   2023-02-08T23:59:59+00:00
Accession:  0001683168-23-000628
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Two directors of CNBX Pharmaceuticals resign effective Jan 31, 2023
-------------------------------------------------------------------

- Dr. Inbar Maymon Pomeranchik resigned as director; no disagreement with management.
- Gil Feiler resigned as director; no disagreement with management.
- Resignations occurred on January 31, 2023; no replacements announced.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1343009/000168316823000628/0001683168-23-000628-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1343009/000168316823000628/cnbx_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-23-000628

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer